![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
High Sustained Virologic Response Rates With Sofosbuvir Regimens Irrespective of Ribavirin Dose Reductions
|
|
|
Reported by Jules Levin
HEP DART 2013, December 8-12, 2013, Big Island, HI, USA
Mark S. Sulkowski,1 Kris V. Kowdley,2 Leslie Bank,3 Julie Ma,4 Anita Mathias,4 John McNally,4 Diana M. Brainard,4 William T. Symonds,4
John G. McHutchison,4 Catherine Stedman,5 Kenneth E. Sherman,6 Raymond T. Chung7
1Johns Hopkins University School of Medicine, Baltimore, MD; 2Virginia Mason Medical Center, Seattle, WA; 3Binghamton Gastroenterology Associates, New York, NY; 4Gilead Sciences Inc., Foster City, CA; 5Christchurch Clinical Studies Trust, Christchurch, New Zealand; 6University of Cincinnati College of Medicine, Cincinnati, OH; 7Massachusetts General Hospital, Boston, MA
![hepDart1.gif](../images/122013/122013-3/hepDart1.gif)
![hepDart2.gif](../images/122013/122013-3/hepDart2.gif)
![hepDart3.gif](../images/122013/122013-3/hepDart3.gif)
![hepDart4.gif](../images/122013/122013-3/hepDart4.gif)
![hepDart5.gif](../images/122013/122013-3/hepDart5.gif)
![hepDart6.gif](../images/122013/122013-3/hepDart6.gif)
![hepDart7.gif](../images/122013/122013-3/hepDart7.gif)
![hepDart8.gif](../images/122013/122013-3/hepDart8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|